These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17576888)

  • 1. Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases.
    Ahmad A; Chen SL; Bilchik AJ
    Arch Surg; 2007 Jun; 142(6):526-31; discussion 531-2. PubMed ID: 17576888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.
    Padman S; Padbury R; Beeke C; Karapetis CS; Bishnoi S; Townsend AR; Maddern G; Price TJ
    Acta Oncol; 2013 Nov; 52(8):1699-706. PubMed ID: 24102180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.
    Kemeny NE; Chou JF; Boucher TM; Capanu M; DeMatteo RP; Jarnagin WR; Allen PJ; Fong YC; Cercek A; D'Angelica MI
    J Surg Oncol; 2016 Apr; 113(5):477-84. PubMed ID: 26830685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
    Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
    HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
    Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
    Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
    Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
    Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
    Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
    Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
    Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
    Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
    Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
    Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after repeat hepatic resection for recurrent colorectal metastases.
    Chiappa A; Zbar AP; Biella F; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.